We are live on ! Find out more
WM

WS Management Portfolio holdings

AUM $1.13B
1-Year Est. Return 53.44%
This Fund
S&P 500
This Quarter Est. Return
+22.62%
1 Year Est. Return
+53.44%
3 Year Est. Return
+163.58%
5 Year Est. Return
+226.76%
10 Year Est. Return
+868.14%
AUM
$963M
AUM Growth
+$36M
Cap. Flow
-$93M
Cap. Flow %
-9.66%
Top 10 Hldgs %
68.17%
Holding
73
New
10
Increased
6
Reduced
14
Closed
18

Top Buys

Rank Stock Value
1
MU icon
Micron Technology
MU
+$29.2M
2
BA icon
Boeing
BA
+$5.38M
3
NEM icon
Newmont
NEM
+$4.56M
4
CTVA icon
Corteva
CTVA
+$3.57M
5
DAL icon
Delta Air Lines
DAL
+$1.98M

Sector Composition

Rank Sector Weight
1 Financials 20.67%
2 Technology 12.03%
3 Communication Services 7.44%
4 Consumer Discretionary 4.71%
5 Consumer Staples 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COP icon
26
ConocoPhillips
COP
$141B
$8.89M 0.92%
222,426
-25,000
-10% -$921K
QQQ icon
27
PUT
Invesco QQQ Trust
QQQ
$449B
$7.84M 0.81%
+25,000
New +$7.34M
PPLI
28
People Inc
PPLI
$3.15B
$7.57M 0.79%
73,286
WFC icon
29
Wells Fargo
WFC
$264B
$7.01M 0.73%
232,373
BA icon
30
Boeing
BA
$167B
$5.99M 0.62%
+28,000
New +$5.38M
LUV icon
31
Southwest Airlines
LUV
$22.2B
$5.09M 0.53%
109,207
-50,000
-31% -$2.17M
SRPT icon
32
Sarepta Therapeutics
SRPT
$1.68B
$4.99M 0.52%
29,276
ASA
33
ASA Gold and Precious Metals
ASA
$962M
$4.98M 0.52%
227,557
NEM icon
34
Newmont
NEM
$98.5B
$4.43M 0.46%
+74,000
New +$4.56M
CTVA icon
35
Corteva
CTVA
$58.6B
$3.87M 0.4%
+100,000
New +$3.57M
PRAA icon
36
PRA Group
PRAA
$683M
$3.71M 0.39%
93,491
-6,509
-7% -$258K
AMZN icon
37
Amazon
AMZN
$2.49T
$3.23M 0.34%
19,840
-51,640
-72% -$8.24M
CRSP icon
38
CRISPR Therapeutics
CRSP
$4.6B
$3.04M 0.32%
19,840
NEM icon
39
CALL
Newmont
NEM
$98.5B
$3M 0.31%
+50,000
New +$3.08M
BMRN icon
40
BioMarin Pharmaceuticals
BMRN
$11.6B
$2.84M 0.3%
32,406
CPRI icon
41
Capri Holdings
CPRI
$1.82B
$2.52M 0.26%
60,000
-59,179
-50% -$1.81M
CNQ icon
42
CALL
Canadian Natural Resources
CNQ
$93.4B
$2.4M 0.25%
+204,200
New +$2.05M
RARE icon
43
Ultragenyx Pharmaceutical
RARE
$2.65B
$2.31M 0.24%
16,692
NTLA icon
44
Intellia Therapeutics
NTLA
$1.49B
$2.29M 0.24%
42,018
DAL icon
45
Delta Air Lines
DAL
$57B
$2.19M 0.23%
+54,341
New +$1.98M
EDIT icon
46
Editas Medicine
EDIT
$411M
$2.12M 0.22%
30,263
XOM icon
47
ExxonMobil
XOM
$642B
$2.07M 0.22%
50,292
CLLS
48
Cellectis
CLLS
$291M
$1.45M 0.15%
53,506
HMHC
49
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$1.41M 0.15%
423,709
-4,774,502
-92% -$14.2M
SGMO
50
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.32M 0.14%
84,811

Similar funds

WS Management's Q4 2020 Portfolio in Review

As of Q4 2020, WS Management held 73 positions worth $963M, up 3.9% from $927M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

WS Management withdrew a net $93M in Q4 2020, closing 18 positions and reducing 14 holdings. Its most notable exit was Twitter, Inc., an estimated $36.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 29% a quarter earlier, followed by Technology and Communication Services.

Against the trend, WS Management opened a new position in Boeing worth $5.99M.

  • WS Management's largest Q4 2020 buy was Boeing: 28,000 shares worth $5.99M.
  • WS Management added most to Micron Technology in Q4 2020, an estimated $29.2M increase.
  • WS Management's biggest Q4 2020 reduction was Berkshire Hathaway Class B, cutting an estimated $59M.
  • WS Management fully exited Twitter, Inc. in Q4 2020, selling an estimated $36.1M.
  • WS Management's ten largest holdings make up 68% of its $963M portfolio in Q4 2020.
  • WS Management opened 10 new positions and closed 18 in Q4 2020.
  • WS Management's portfolio value rose 3.9% quarter-over-quarter to $963M.

Based on WS Management's 13F filing for Q4 2020, filed 11 Feb 2021.